HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shi-Ying Xuan Selected Research

complement C3f

1/2014Serum complement C3f and fibrinopeptide A are potential novel diagnostic biomarkers for non-alcoholic fatty liver disease: a study in Qingdao Twins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shi-Ying Xuan Research Topics

Disease

14Non-alcoholic Fatty Liver Disease
02/2020 - 09/2008
6Hepatocellular Carcinoma (Hepatoma)
01/2017 - 05/2005
3Coronary Artery Disease (Coronary Atherosclerosis)
07/2016 - 04/2016
3Hepatitis
04/2015 - 03/2007
2Insulin Resistance
04/2016 - 04/2014
2Inflammation (Inflammations)
12/2015 - 03/2007
2Liver Diseases (Liver Disease)
04/2015 - 01/2015
1Fistula
12/2018
1Retinoblastoma (Glioblastoma, Retinal)
11/2015
1Carcinogenesis
11/2015
1Autoimmune Hepatitis
04/2015
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2015
1Alzheimer Disease (Alzheimer's Disease)
05/2012
1Fibrosis (Cirrhosis)
03/2011
1Hepatitis C
03/2011

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2017 - 03/2013
3LipidsIBA
02/2020 - 04/2014
2Triglycerides (Triacylglycerol)IBA
07/2016 - 12/2015
2AdiponectinIBA
07/2016 - 03/2016
2Leptin ReceptorsIBA
04/2016 - 03/2016
2ApolipoproteinsIBA
03/2016 - 04/2014
2Phospholipases (Phospholipase)IBA
04/2014 - 03/2013
2EnzymesIBA
04/2014 - 03/2013
2Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2008 - 03/2007
1Ferritins (Ferritin)IBA
12/2017
1LDL Lipoproteins (beta Lipoproteins)IBA
07/2016
1oxidized low density lipoproteinIBA
07/2016
1CholesterolIBA
07/2016
1Glucose (Dextrose)FDA LinkGeneric
07/2016
1Angiotensin IIIBA
06/2016
1Tumor Necrosis FactorsIBA
03/2016
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2016
1SterolsIBA
03/2016
1microsomal triglyceride transfer proteinIBA
03/2016
1Superoxide DismutaseIBA
03/2016
1O(4)-methylthymidine triphosphateIBA
03/2016
1MicroRNAs (MicroRNA)IBA
11/2015
1Isoleucine (L-Isoleucine)FDA Link
01/2015
1Methionine (L-Methionine)FDA Link
01/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2015
1AntioxidantsIBA
04/2014
1Biomarkers (Surrogate Marker)IBA
01/2014
1Fibrinopeptide AIBA
01/2014
1Peptides (Polypeptides)IBA
01/2014
1complement C3fIBA
01/2014
1Interleukin-1 (Interleukin 1)IBA
05/2012
1Interleukin-33IBA
05/2012
1DNA (Deoxyribonucleic Acid)IBA
07/2011
1HLA Antigens (Human Leukocyte Antigens)IBA
05/2011
1HLA-DQB1 antigen (HLA DQB1)IBA
05/2011
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2011
1HLA-DRB1 Chains (HLA DRB1)IBA
12/2010
1ORALIT (ORS)IBA
12/2010
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2008
1LeptinIBA
09/2008
1Surface Antigens (Surface Antigen)IBA
03/2007
1ParaffinIBA
03/2007
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
03/2007
1Docetaxel (Taxotere)FDA Link
05/2005

Therapy/Procedure

1Transjugular Intrahepatic Portasystemic Shunt
12/2018
1Cannula
12/2018
1Liver Transplantation
04/2015
1Therapeutics
04/2015
1Precision Medicine
04/2015